3-(pyrrolidin-1-yl)-propanal | 127554-91-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 3-(pyrrolidin-1-yl)-propanal
• 英文别名: 3-(Pyrrolidin-1-yl)propanal；3-pyrrolidin-1-ylpropanal
• CAS: 127554-91-0
• 化学式: C₇H₁₃NO
• 分子量: 127.186
• InChiKey: SUDOFTVBCPEFQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  四氢吡咯 、 丙烯醛 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 四氢呋喃 为溶剂， 反应 0.25h， 以95%的产率得到3-(pyrrolidin-1-yl)-propanal
  参考文献：
  名称：

  Chesney, Antony; Marko, Istvan E., Synthetic Communications, 1990, vol. 20, # 20, p. 3167 - 3180

  摘要：

  DOI：

文献信息

• Synthesis of cyclic compounds
  申请人：——

  公开号：US20040110966A1

  公开（公告）日：2004-06-10

  A method for the preparation of a compound of formula (II) wherein R 1 and R 2 are independently H, alkyl, alkoxy, oxoalkyl, alkenyl, aryl or arylalkyl whether unsubstituted or substituted, optionally interrupted by one or more hetero atoms, straight chain or branched chain, hydrophilic, hydrophobic or fluorophilic; R 3 , R 4 , R 5 and R 6 are independently or all hydrogen or halogen; provided that at least two of the R 3 , R 4 , R 5 and R 6 are halogens.

  一种制备式（II）化合物的方法，其中R1和R2独立地为H、烷基、烷氧基、氧代烷基、烯基、芳基或芳基烷基，无论是否取代，可选地由一个或多个杂原子中断，直链或支链，亲水性、疏水性或亲氟性；R3、R4、R5和R6独立地或全部为氢或卤素；但至少两个R3、R4、R5和R6为卤素。
• Electrophoresis gels and cross-linking agents for their preparation
  申请人：The University of Melbourne

  公开号：US20010020079A1

  公开（公告）日：2001-09-06

  Method of separating molecules by providing a cross-linked polymer gel having a cross-linking moiety of the formula 1 wherein X, X′, Y, Z and R 2 are as defined in the specification. A sample containing the molecules to be separated is placed on the gel, and the gel is subjected to a separation technique.

  通过提供具有交联单体的交联聚合物凝胶来分离分子的方法，其中交联单体的结构如下所示，其中X、X′、Y、Z和R2如规范中定义。将含有待分离分子的样品放置在凝胶上，并对凝胶进行分离技术处理。
• THERAPEUTIC ISOXAZOLE COMPOUNDS
  申请人：Kaplan Alan P.

  公开号：US20090062252A1

  公开（公告）日：2009-03-05

  The invention provides a compound of formula I: wherein A 1 , A 2 , A 3 , R 1 , X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of monoamine oxidase B (MAO-B) enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.

  该发明提供了一种式I的化合物：其中A1、A2、A3、R1、X、Y和B具有本文所描述的任何值，以及这些化合物的盐、包含这些化合物的组合物，以及包括给予这些化合物的治疗方法。这些化合物是单胺氧化酶B（MAO-B）酶功能的抑制剂，对于改善认知功能和治疗动物的精神障碍非常有用。
• Sulfonamide compound
  申请人：Matsubara Koki

  公开号：US20090048223A1

  公开（公告）日：2009-02-19

  A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G 1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G 2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; G 3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkoxycarbonyl group, an acyl group, an acyloxy group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; Y represents a single bond, or —C(R 3 )(R 4 )— (R 3 and R 4 represent hydrogen atom, or an alkyl group, or alkylene groups which combine together to form a saturated hydrocarbon ring group); G 4 represents hydroxyl group (Y is a single group), or —N(R 1 )(R 2 ) (R 1 and R 2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, a saturated heterocyclic group, an alkylsulfonyl group, an acyl group, or an amidino group); G 5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.

  由以下化学式表示的化合物：[A代表含氮饱和环；m表示0到2的整数；n表示1到4的整数；G1代表氢原子、氯原子、羟基、烷氧基或氨基；G2代表卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基；G3代表氢原子、卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基；Y代表单键，或-C(R3)(R4)-（R3和R4代表氢原子、烷基或烷烯基，它们结合在一起形成饱和碳氢环基）；G4代表羟基（Y是单个基），或-N(R1)(R2)（R1和R2代表氢原子、烷基、芳基、烯基、炔基、饱和杂环基、烷基磺酰基、酰基或胺基）；G5是A的环构成碳原子上的取代基，代表氢原子、氟原子或烷基]或其盐、或作为前药的衍生物，其强力抑制Rho激酶。
• Thiazolidinones, their production and use as pharmaceutical agents
  申请人：Siemeister Gerhard

  公开号：US20070037862A1

  公开（公告）日：2007-02-15

  Thiazolidinones of general formula I in which Q, A, B, X, R 1 and R 2 have the meanings that are indicated in the description, as well as those of general formula IA in which Q, A, B, X, R 1 and R 2a have the meanings that are indicated in the description, their production and use as inhibitors of the polo-like kinase (PLK) for treating various diseases as well as intermediate products for the production of thiazolidinones are described.

  通用公式I中的噻唑烷酮，其中Q、A、B、X、R1和R2具有描述中指示的含义，以及通用公式IA中的噻唑烷酮，其中Q、A、B、X、R1和R2ahave具有描述中指示的含义，描述了它们作为极化样激酶（PLK）抑制剂用于治疗各种疾病以及用于噻唑烷酮的生产和使用的中间体产品。